Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.

For each company you can evaluate:
* Summary: At a glance review of agreements, products and R&D pipeline.
* Overview: Background, ownership structure and research techniques they have developed for drug discovery.
* Agreements: Key details of who the company is collaborating with, and on what.
* Product Portfolio: Product monographs, mechanism of action and indications approved and in development.
* R&D Pipeline: Concise summaries of products in research covering status, indication and clinical trials.
* Financials: An analysis of financial performance including P&L, R&D expenditure and funding. Incorporated on 23rd February 1907, the Kirin Group comprises a diversified number of companies concentrating on various sectors. The structure of the Kirin Group was reorganised in 2001 into a holding company, business companies and internal business units called “companies.” Kirin Brewery operates both as a business company managing the Japanese beer and happo-shu (low-malt beer) business, and as a holding company overseeing each business and strengthening group operations.